Vaccination

France's Sanofi halts work on mRNA Covid vaccine

French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against COVID-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.

Diseases, Conditions, Syndromes

German-Chinese coronavirus vaccine trial begins in China

Clinical trials on humans have begun in China for a potential coronavirus vaccine developed by German pharmaceutical group BioNTech with Chinese company Fosun Pharma, the companies said Wednesday.

Diseases, Conditions, Syndromes

Portugal fears a fourth wave from the Delta variant

Portugal fears a fourth wave of the coronavirus pandemic may take hold with the highly contagious Delta variant now accounting for more than 60 percent of new cases in the capital.

Vaccination

Medicago and GSK to begin final Covid-19 vaccine trials

Canada's Medicago and British pharmaceutical giant GlaxoSmithKline (GSK) announced Thursday the launch of phase 2 and 3 clinical trials on a COVID-19 vaccine, one of a series of candidates being developed worldwide.

page 1 from 3